Lisata Therapeutics Inc
Research Lisata Therapeutics Inc (LSTA) on Bullrun: market cap USD 15.87M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerLSTA
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 15.87M
- Financial periodQ2 2026
- RevenueUSD 0
- Net income-USD 2.93M
- Free cash flow-USD 2.65M
Valuation Snapshot
latest market cap is USD 15.87M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 170.00K | -USD 16.59M | -USD 15.98M | n/a | -1.91 | USD 15.96M | USD 0 | USD 14.86M |
| FY2024 | USD 1.00M | -USD 19.99M | -USD 19.36M | n/a | -2.4 | USD 16.21M | USD 137.00K | USD 29.57M |
| FY2023 | USD 0 | -USD 20.84M | -USD 20.03M | n/a | -2.58 | USD 22.59M | USD 168.00K | USD 48.15M |
| FY2022 | USD 0 | -USD 54.23M | -USD 21.46M | n/a | -10.47 | USD 32.15M | USD 561.00K | USD 66.58M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 15.87M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 16.43M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 25.06M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 22.22M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 19.89M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 50.22M | n/a | n/a | n/a |
About Lisata Therapeutics Inc
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with range of anti-cancer regimens.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Lisata Therapeutics Inc's market cap?
Lisata Therapeutics Inc's market capitalization is USD 15.87M.
What does Lisata Therapeutics Inc do?
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with range of anti-cancer regimens. Lisata Therapeutics, Inc. was formerly known as Caladrius Biosciences, Inc.